Renaissance Technologies - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 35 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$362,000
-19.6%
1,005,300
-1.3%
0.00%
-100.0%
Q1 2017$450,000
-13.0%
1,019,000
-1.5%
0.00%0.0%
Q4 2016$517,000
+12.4%
1,034,500
+13.9%
0.00%0.0%
Q3 2016$460,000
-47.5%
908,100
+3.7%
0.00%
-50.0%
Q2 2016$876,000
+59.0%
876,100
+8.6%
0.00%
+100.0%
Q1 2016$551,000
-39.8%
806,700
+6.6%
0.00%
-50.0%
Q4 2015$916,000
-42.8%
757,000
+5.5%
0.00%
-50.0%
Q3 2015$1,600,000
-17.9%
717,400
-14.3%
0.00%0.0%
Q2 2015$1,950,000
+43.9%
837,023
+32.8%
0.00%
+33.3%
Q1 2015$1,355,000
+53.5%
630,391
+63.5%
0.00%
+50.0%
Q4 2014$883,000
+39.9%
385,483
+63.1%
0.00%0.0%
Q3 2014$631,000
-39.6%
236,415
-15.5%
0.00%0.0%
Q2 2014$1,044,000
-0.9%
279,922
+212.7%
0.00%
-33.3%
Q1 2014$1,053,000
+48.9%
89,522
+5.6%
0.00%
+50.0%
Q4 2013$707,000
+46.1%
84,800
+62.5%
0.00%
+100.0%
Q3 2013$484,000
+49.4%
52,200
+57.7%
0.00%0.0%
Q2 2013$324,00033,1000.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 17,200$9,0000.02%
TWO SIGMA SECURITIES, LLC 18,332$9,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$475,0000.00%
Virtu KCG Holdings LLC 58,727$29,0000.00%
Renaissance Technologies 1,034,500$517,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 17,280$9,0000.00%
MORGAN STANLEY 8,500$4,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders